Atrial fibrillation: Current understandings and research imperatives

Journal of the American College of Cardiology

Volumn 22, Issue 7, 1993, Pages 1830-1834

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DILTIAZEM; MAGNESIUM SULFATE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN;

ARTICLE; CORONARY ARTERY DISEASE; HEART ATRIUM FIBRILLATION; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESEARCH;

ANTI-ARRHYTHMIA AGENTS; ASPIRIN; ATRIAL FIBRILLATION; CATHETER ABLATION; CEREBROVASCULAR DISORDERS; HEART CONDUCTION SYSTEM; HUMAN; INCIDENCE; INTRACRANIAL EMBOLISM AND THROMBOSIS; NATIONAL INSTITUTES OF HEALTH (U.S.); UNITED STATES; WARFARIN;

EID: 0027440556     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(93)90765-S     Document Type: Article

References (57)

1. Basic mechanisms of atrial fibrillation and atrial flutter
2. Precursors of atrial fibrillation in a population based cohort: the Framingham Study [abstract]
3. Epidemiologic features of chronic atrial fibrillation the Framingham Study
4. Echocardiographic predictors of nonrheumatic atrial fibrillation [abstract]
5. Thromboembolism in patients with atrial fibrillation
6. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
7. Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation: The Lausanne Stroke Registry
8. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study
9. The natural history of lone atrial fibrillation: a population-based study over three decades
10. Is atrial fibrillation an independent risk factor for stroke?
11. Risk factors for ischemic stroke a prospective study in Rochester Minnesota
12. Analysis of risk factors for stroke in a cohort of men born in 1913
13. Atrial fibrillation as a self sustaining arrhythmia independent of focal discharge
14. On the multiple wavelet hypothesis of atrial fibrillation
15. A computer model of atrial fibrillation
16. Total mapping of atrial excitation during acetylcholine-induced atrial flutter and fibrillation in the isolated canine heart
17. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation
18. Circus movement and rapid atrial muscle as a mechanism of tachycardia. III. The “leading circle” concept: a new model of circus movement in cardiac tissue without the involvement of an anatomic obstacle
19. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation
20. Studies on auricular tachycardia caused by aconitine administration
21. Cholinergically mediated tachyarrhythmias induced by a single extra stimulus in the isolated canine right atrium
22. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASK study
23. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
24. Stroke Prevention in Atrial Fibrillation Study; final results
25. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
26. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
27. The pharmacologic treatment of atrial fibrillation
28. Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm: relation to left atrial size
29. Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion
30. Antithrombotic therapy in atrial fibrillation
31. Management of atrial fibrillation
32. Designing clinical trials for paroxysmal atrial tachycardia and other paroxysmal arrhythmias
33. Prevention of symptomatic recurrences of paroxysmal atrial fibrilation in patients initially tolerating antiarrhythmic therapy: a multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring
34. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias: a randomized, placebo-controlled, crossover trial in patients tolerating oral therapy
35. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized controlled trials
36. Preliminary report effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
37. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
38. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation
39. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation
40. Low-dose amiodarone for atrial fibrillation: time for a prospective study?
41. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation
42. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function
43. Proarrhythmia in patients treated for atrial fibrillation or flutter
44. Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction
45. What is meant by a “controlled” ventricular rate in atrial fibrillation?
46. Magnesium and cardiovascular disease
47. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias
48. Catheter technique for closed-chest ablation of the atrioventricular conduction system
49. Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction: results of a prospective, international, multicenter study
50. Closed chest catheter desiccation of the atrioventricular junction using radiofrequency energy—a new method of catheter ablation
51. Radiofrequency catheter ablation of the atrioventricular junction from the left ventricle
52. Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction
53. Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction
54. Statistical Analysis of Clinical Trials
55. A review of surgery for atrial fibrillation